ESG News For Clinical Data, Inc.

nference’s federated AI platform is being leveraged to provide access to the deepest clinical data to generate insights and better inform decision-making

The initiative, “Change the Odds: Uniting to Improve Cancer Outcomes” aims to enhance awareness of and access to cancer screening, clinical trials and support in medically underrepresented communities across the United States

Multiyear collaboration with Albany Area Primary Health Care and Feeding the Valley Food Bank to improve knowledge of diabetes self-management for Albany residents where diabetes is 5% higher than the statewide average

Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.Expands on the initial offering of all patented medicines and vaccines available in the U.S. or EU to now include off-patent medicines, bringing total offering from 23 to around 500 products.Builds on already delivered medicines and vaccines along with medical training and supply chain support to Rwanda and advanced conversations with 16 other Accord country governments for supply and health system support.

VirtualHealth will receive computing credits and technical expertise from Amazon Web Services for cloud solutions designed to reduce healthcare disparities and advance health equity

 Analysis of randomized controlled trial data shows non-Caucasian high-risk PCI patients significantly benefit from Impella-support

STALICLA will be a leading contributor to the Euro-Global Platform for Mechanism-based Drug Repurposing (REPO4EU) consortium, with a EUR 1.7 million budget allocated to STALICLA Discovery and Data Science (DDS) unit

The virtual healthcare platform and Ukrainian humanitarian non-profit will focus on urgent care needs, prescription renewals, and ordering lab tests for thousands of refugees in the U.S.

Pfizer will provide all its current and future patent-protected medicines and vaccines available in the U.S. or EU on a not-for-profit basis to 45 lower-income countries.Rwanda, Ghana, Malawi, Senegal and Uganda are the first five countries to commit to join the Accord. Health officials in these countries will help identify and resolve hurdles beyond supply to inform the roll out in all 45 lower-income countries.Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap and help create a healthier world for 1.2 billion people.

Clinical data clear major test for the first precision neurodevelopmental disorders discovery platform, with a first application in Autism Spectrum Disorder (ASD)

In partnership with The Geneva Foundation and supporting grant from the Quebec Ministry of Economy and Innovation, Emovi will launch the 24-month clinical project within US Army clinics at Fort Bragg and High Point University, North Carolina, USA

Castor named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Strategic partnership to focus on improving maternal outcomes

Greenwich LifeSciences to Partner with Susan G. Komen Race for the Cure Houston

Expanded agreement brings the total number of COVID-19 vaccine doses to be supplied to the U.S. government for donation to one billionEffort contributes to companies’ pledge to deliver two billion COVID-19 vaccine doses to low- and middle-income countries by the end of 2022

Building on Pfizer’s longstanding commitment to fight infectious diseases, grants will help address urgent needs of U.S. and global partners on the front lines of the pandemic Donations complement Pfizer’s COVID-19 R&D investments, as well as collective scientific and philanthropic contributions made by the biopharmaceutical industryU.S. Patient Assistance Program and other programs respond to changing needs of patients and medical community

Three leading biopharmaceutical companies have announced programs enabling employees with medical and laboratory expertise to volunteer their services to local healthcare systems and those hardest hit by COVID-19.

In urgent response to Wuhan Huoshenshan Hospital's request for more accurate, rapid and comprehensive diagnostic platform, Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, has announced its donation of GENETRON S5 (China National Medical Device Registration 20193220820) semiconductor high-throughput sequencer and supporting instruments to the hospital. All equipment has arrived at the hospital and went into immediate use.

MiraMed Global Services, Inc. (MiraMed), a leader in healthcare revenue cycle management (RCM) services and business process outsourcing (BPO) solutions, is pleased to announce that its recent Circle of Warmth campaign raised $75,000+ dollars for those in need this winter. This money is being used to source the durable EMPWR Coat from the Empowerment Plan that can transform into a sleeping bag at night or an over-the-shoulder bag when not in use. This

“REKOOP” is the first Bedding solution to use Applied DNA’s CertainT Platform and Reliance Industries’ Recron GreenGold fiber for source verification and traceability of recycled polyester across the supply chain; Arrives in US Q1 2019

New Partnership to Kick-Off International Expansion